Ticker: BBIO

Company: BridgeBio Pharma, Inc.

Person: Maricel Apuli, officer

Transaction date: Nov. 16, 2025

Reporting date: Nov. 18, 2025

Average share price: 66.39

Sold 4781.0 shares for 317410.59